Single and Double Knockout of TR2 and TR4 Receptors
TR2 和 TR4 受体的单次和双次敲除
基本信息
- 批准号:6562001
- 负责人:
- 金额:$ 37.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-02-01 至 2007-01-31
- 项目状态:已结题
- 来源:
- 关键词:embryo /fetus tissue /cell culture fertility gene expression gene targeting genetically modified animals hematopoiesis immunocytochemistry in situ hybridization insulinlike growth factor laboratory mouse microarray technology northern blottings nuclear receptors osteoblasts phenotype pituitary gland polymerase chain reaction protein structure function receptor expression somatotropin striated muscles testis thyroid hormones thyrotropin thyroxine western blottings
项目摘要
DESCRIPTION (provided by applicant): The goal of our proposed research is to explore the effects of targeted disruption of the nuclear orphan receptors TR2 and TR4, as well as consequences of disruption of the two genes in combination, in order to determine the physiological roles of these receptors. We hypothesize that both TR2 and TR4 play significant roles in the regulation of developmental, physiological, and behavioral systems. To determine the specific roles of TR2 and TR4 in vivo, we will employ mouse models exhibiting ablation of either orphan receptor, as well as animals exhibiting simultaneous ablation of both receptors. Specific aim 1: Characterization of TR4 knockout/Beta-gal knockin (TR4 -/-) mice. Specific aim 2: Characterization of TR2 knockoutJBeta-gal knockin (TR2 -/-) mice. We hypothesize this receptor is more important in early stages of development, and that TR2 -/- mice may die pre- or postnatally. Mortality will be investigated by morphological and histological analyses, and animals surviving to adulthood will be assessed for growth rate and fertility. Specific aim 3: Characterization of TR2/TR4 double knockout mice. Analysis of the double knockout animals will follow the approach described in Specific Aim 2, and the phenotypes will be analyzed in comparison to TR2 knockout, TR4 knockout, and wildtype mice. Specific Aim 4: Analysis of the effects of TR4 and/or TR2 ablation on target gene regulation. TR4, TR2, and TR2/TR4 knockout animals will be tools to study the known target genes of these orphan receptors in an in vivo system, and to confirm the physiological significance of the identified regulatory pathways, and provide sources of material for the screening of novel TR2/TR4 target genes. 4a: Determination of effect of TR4 and/or TR2 target gene ablation on known target gene expression. Compare endogenous gene expression, and protein levels of TR4 and TR2 downstream targets in knockout animals versus wildtype controls. 4b: Identifiy novel genes regulated uniquely or differentially by TR4 and/or TR2 through the use of gene microarray technology, we hope to dissect the differences in target gene regulation mediated by TR4 and TR2 and, in this way, further understand the roles of these enigmatic orphan receptors in mammalian development and physiology. In summary, this proposal provides us the first opportunity to study the potential in vivo physiological roles of the TR2 and TR4 orphan nuclear receptors.
描述(由申请人提供):我们拟议研究的目标是探索靶向破坏核孤儿受体TR 2和TR 4的影响,以及两种基因联合破坏的后果,以确定这些受体的生理作用。我们推测TR 2和TR 4在发育、生理和行为系统的调节中起重要作用。为了确定TR 2和TR 4在体内的具体作用,我们将采用表现出任一孤儿受体消融的小鼠模型,以及表现出两种受体同时消融的动物。具体目的1:TR 4敲除/β-gal敲入(TR 4-/-)小鼠的表征。具体目的2:TR 2敲除/β-gal敲入(TR 2-/-)小鼠的表征。我们假设这种受体在发育的早期阶段更重要,TR 2-/-小鼠可能在出生前或出生后死亡。将通过形态学和组织学分析研究死亡率,并评估存活至成年的动物的生长率和生育力。具体目标3:TR 2/TR 4双敲除小鼠的表征。双敲除动物的分析将遵循特定目标2中描述的方法,并将与TR 2敲除、TR 4敲除和野生型小鼠相比分析表型。具体目的4:分析TR 4和/或TR 2消融对靶基因调控的影响。TR 4、TR 2和TR 2/TR 4敲除动物将成为在体内系统中研究这些孤儿受体的已知靶基因的工具,并证实所鉴定的调控通路的生理意义,并为筛选新的TR 2/TR 4靶基因提供材料来源。4a:确定TR 4和/或TR 2靶基因消融对已知靶基因表达的影响。比较敲除动物与野生型对照中TR 4和TR 2下游靶标的内源性基因表达和蛋白水平。4b:通过基因微阵列技术鉴定TR 4和/或TR 2独特或差异调控的新基因,我们希望能够剖析TR 4和TR 2介导的靶基因调控的差异,从而进一步了解这些神秘孤儿受体在哺乳动物发育和生理中的作用。总之,这一建议为我们提供了第一次机会,研究潜在的体内生理作用的TR 2和TR 4孤儿核受体。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHAWNSHANG CHANG其他文献
CHAWNSHANG CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHAWNSHANG CHANG', 18)}}的其他基金
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8527735 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8459341 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8053554 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8830282 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8693963 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Stromal AR Roles in Prostate Hyperplasia and Cancer
基质 AR 在前列腺增生和癌症中的作用
- 批准号:
8628080 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Non-AR mediated DHT-promoted Bladder Cancer initiation and progression
非 AR 介导的 DHT 促进膀胱癌的发生和进展
- 批准号:
8115717 - 财政年份:2011
- 资助金额:
$ 37.01万 - 项目类别:
Androgen Receptor in B Cell Development and Functions
B 细胞发育和功能中的雄激素受体
- 批准号:
7996771 - 财政年份:2010
- 资助金额:
$ 37.01万 - 项目类别:
New Mice Models for Studies of Androgen Receptor in Prostate Cancer
用于研究前列腺癌雄激素受体的新小鼠模型
- 批准号:
7996057 - 财政年份:2008
- 资助金额:
$ 37.01万 - 项目类别:
New Mice Models for Studies of Androgen Receptor in Prostate Cancer
用于研究前列腺癌雄激素受体的新小鼠模型
- 批准号:
8204965 - 财政年份:2008
- 资助金额:
$ 37.01万 - 项目类别:
相似国自然基金
Exploring Changing Fertility Intentions in China
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国学者研究基金
相似海外基金
The elasticity of male fertility by means of phonon microscopy
通过声子显微镜观察男性生育能力的弹性
- 批准号:
EP/Y002857/1 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Research Grant
Protecting spermatogonial stem cells from chemotherapy-induced damage for fertility preservation in childhood cancer
保护精原干细胞免受化疗引起的损伤,以保存儿童癌症的生育能力
- 批准号:
MR/Y011783/1 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Fellowship
The interaction of HELB with RPA and its role in human fertility
HELB 与 RPA 的相互作用及其在人类生育力中的作用
- 批准号:
MR/Y012070/1 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Research Grant
SBIR Phase II: Novel progesterone biosensor for monitoring fertility health
SBIR II 期:用于监测生育健康的新型黄体酮生物传感器
- 批准号:
2341568 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Cooperative Agreement
LTREB: How does inter-annual variation in rainfall interact with soil fertility and chronic disruption of soil moisture dynamics to alter soil C cycling in tropical forests?
LTREB:降雨量的年际变化如何与土壤肥力和土壤湿度动态的长期破坏相互作用,从而改变热带森林的土壤碳循环?
- 批准号:
2332006 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Continuing Grant
Towards Low Cost Soil Fertility Sensor Systems for Smallholder Food Security in Kenya
为肯尼亚小农粮食安全打造低成本土壤肥力传感器系统
- 批准号:
EP/Y001826/1 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Research Grant
How do Fbxo7 and PI31 control sperm morphogenesis and male fertility?
Fbxo7 和 PI31 如何控制精子形态发生和男性生育能力?
- 批准号:
BB/X014177/1 - 财政年份:2024
- 资助金额:
$ 37.01万 - 项目类别:
Research Grant
Regulation of follicle-stimulating hormone synthesis and fertility by inhibins
抑制素对促卵泡激素合成和生育能力的调节
- 批准号:
490057 - 财政年份:2023
- 资助金额:
$ 37.01万 - 项目类别:
Operating Grants
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 37.01万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Experiences of early-stage cervical cancer and fertility sparing surgery: an ethnographic and co-creative approach to social and intimate domains
早期宫颈癌和保留生育手术的经验:社会和亲密领域的民族志和共同创造方法
- 批准号:
EP/Y023617/1 - 财政年份:2023
- 资助金额:
$ 37.01万 - 项目类别:
Fellowship